CTCFL and endometrial cancer: In the present study we have performed comprehensive molecular profiling of a unique sample collection of fresh frozen endometrial cancer precursor lesions in parallel with clinically annotated primary and metastatic endometrial carcinoma lesions to explore potential links between disease progression and CTCF mutations, aberrant expression of CTCFL/BORIS and CTCFL/BORIS DNA methylation.